Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have ...
US biotech TORL BioTherapeutics has raised $96 million in a series C round to push its lead antibody-drug conjugate, ...
Daytime Emmy Awards participation - 2 nomination for 'Shelter Me: Cancer Pioneers' Comparative Oncology documentary that ...
HOUSTON, TX and SUNSHINE COAST, QUEENSLAND / ACCESS Newswire / October 6, 2025 / BrYet US, Inc. (“BrYet”), a biotechnology innovator developing a drug with the potential to be a first-in-class ...
RAJSHAHI, Oct 8, 2025 (BSS) - A total of 5,64,123 children aged between nine months and under 16 years are set to receive ...
Cellectar Biosciences, Inc. (NASDAQ:CLRB) (“Cellectar” or the “company”), a late-stage biotechnology company focused on the ...
Researchers presented guidelines for vaccination against respiratory illness in individuals with cardiovascular disease.
NDTV Profit on MSN
Stock Market Today: All You Need To Know Going Into Trade On Oct. 8
The benchmark indices of the NSE Nifty 50 and BSE Sensex on Tuesday exhibited gains for a fourth consecutive session, post ...
The TROPION-Breast02 trial is the first to show overall survival benefit in this patient population, indicating a potential ...
Sejeong Son of FirstLaw PC draws on three cases to explain how South Korean courts are reinterpreting the territoriality principle in patent law in response to the increasingly important realities of ...
Daiichi Sankyo submits sNDA to Japan’s MHLW for Enhertu plus pertuzumab to treat patients with HER2 positive unresectable or recurrent breast cancer: Tokyo Wednesday, October 8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback